Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2760 of 5804
-
Immune-Guiding antibody aims to clean up remaining cancer cells after transplant
Disease control OngoingThis phase 1 pilot study examines the feasibility and safety of mosunetuzumab after autologous stem cell transplant for patients with aggressive B cell lymphomas. Mosunetuzumab is an antibody that has been engineered to attach to two target cells in the immune system: T cells tha…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Sleep apnea treatment may ease PCOS symptoms
Disease control OngoingIn this study, the researchers are trying to learn more about the relationship between Polycystic Ovary Syndrome and Obstructive Sleep Apnea (OSA). Obstructive Sleep Apnea is a sleep-related breathing disorder that involves a decrease or complete stop in airflow. The purpose of t…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can texts and calls help taxi drivers shed pounds?
Disease control Recruiting nowThe researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SE…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can zapping two brain areas at once stop Parkinson's freezing?
Symptom relief TerminatedThe aim of the current study was to verify whether high-dose TMS treatment of the motor and cognitive cortices is more effective in alleviating FOG than conventional-dose TMS of the motor cortex only. Specifically, investigator hypothesized that the effect of dual-target TMS on F…
Phase: NA • Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New cancer drug YL202 enters first human trials
Disease control OngoingThis is a phase 1, multicenter, open-label, first-in-human study of YL202 conducted in the United States and China. The study will evaluate the safety and tolerability of YL202 in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated NSCLC …
Phase: PHASE1 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Telehealth therapy aims to ease pandemic fear in older veterans
Symptom relief CompletedOlder adults have been disproportionately impacted and distressed by the novel coronavirus (COVID-19) pandemic. Social distancing and stay-at-home orders have increased older adults' risk of social isolation and loneliness that will has led to a pandemic-induced fear of being in …
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Could an allergy drug protect kidneys in diabetes?
Disease control CompletedThe prevalence of diabetes mellitus is increasing worldwide, and its complications are one of the leading causes of mortality from non-communicable diseases. Due to the high prevalence of diabetes and because 30-40% of diabetic patients \[both type 1 (T1DM) and type 2 (T2DM) diab…
Phase: PHASE2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Virtual reality could ease stress of bone marrow transplants
Symptom relief OngoingThe goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Electric suit may ease stroke stiffness and improve balance
Symptom relief CompletedSpasticity is a common and debilitating complication in neurological conditions such as multiple sclerosis, cerebral palsy, and stroke. Stroke, a leading cause of global disability and death, occurs when blood flow to the brain is disrupted, causing neuronal damage. Approximately…
Phase: NA • Sponsor: Institut De La Colonne Vertebrale Et Des Neurosciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Experimental pill combo takes on tough leukemia
Disease control Recruiting nowThis is an open label, dose escalation Phase I single institution pilot study for relapsed and refractory AML patients using CC-486 (oral azacitidine) with venetoclax. At the completion of dose escalation and after establishment of the MTD or recommended dose of CC-486 with venet…
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New prostate cancer drug may cause fewer side effects than current option
Disease control CompletedResearchers are looking for a better way to treat men who have biochemically recurrent hormone-naïve prostate cancer. Hormone-naïve prostate cancer is a prostate cancer that has not yet been treated with hormonal therapy including androgen deprivation therapy (ADT). Biochemicall…
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Vitamin d may ease Chemo's nerve pain
Symptom relief TerminatedThis is a two-arm randomized clinical trial in which 80 participants with Vitamin D deficiency and scheduled to begin taxane-based chemotherapy will be randomized to either: 1) prescribed vitamin D replacement or 2) standard of care.
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Smart 'Poop' device could revolutionize constipation care
Knowledge-focused Recruiting nowChronic constipation (CC) is a common condition that affects up to 25% of the population in North America. It poses a major burden on the healthcare cost. The pathophysiology of this condition is poorly understood and consequently there are inadequate treatments. Current diagnost…
Phase: NA • Sponsor: The California Medical Innovations Institute, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Double drug combo offers hope for migraine sufferers
Symptom relief CompletedMigraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will how effective the combination use of ubrogepant and atogepant is in treating adult participants with migraine.…
Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Steam treatment for prostate troubles under the microscope in 1000-Man study
Symptom relief Recruiting nowThis study is to assess the clinical data of Rezum (water vapor therapy) in patients with BPO (benign prostate obstruction) and male LUTS (lower urinary tract symptoms) in terms of efficacy, durability and safety in a large, prospective, multi-center cohort consisting of 1000 "re…
Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Brain wave tracking may improve care after severe head trauma
Knowledge-focused Recruiting nowThis study is a randomized Phase 2 trial to determine the feasibility of real-time electrocorticographic monitoring of spreading depolarizations (SD) to guide implementation of a tier-based protocol of intensive care therapies, aimed at SD suppression, for the management of patie…
Phase: PHASE2 • Sponsor: University of Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Could a common heart drug spark new muscle growth in babies with heart defects?
Disease control Recruiting nowHeart failure is a common long-term complication in patients with congenital heart disease (CHD). Medical treatments to promote regeneration of new healthy heart muscle cells have the potential to provide new heart failure treatments for these patients. The development of such th…
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Electric brain zap tames mania in small trial
Symptom relief CompletedMania is a core symptom of bipolar disorder involving periods of euphoria. Decreased inhibitory control, increased risk-taking behaviors, and aberrant reward processing are some of the more recognized symptoms of bipolar disorder and are included in the diagnostic criteria for ma…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Shoulder surgery recovery: PRP vs steroids – which works better?
Disease control OngoingProspective, multicenter, randomized, single-blinded, parallel group,placebo-controlled,three-group establishment of specific treatment regimen for subtypes of tendinopathy
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Kidney patients take charge of blood pressure in new trial
Disease control Recruiting nowThe proposed research will evaluate if patients managing their blood pressure medications under the guidance of a clinical pharmacist works better to lower blood pressure than patients monitoring their blood pressure at home and the standard care. 60 Veterans with chronic kidney …
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC